Possible	JJ	possible JJ PennPOS
involvement	NN	involvement NN PennPOS
of	IN	of pp-f NUPOS
pirfenidone	NN	pirfenidone NN PennPOS
metabolites	NNS	metabolite NNS PennPOS
in	IN	in IN PennPOS
the	DT	the dt NUPOS
antifibrotic	JJ	antifibrotic JJ PennPOS
action	NN	action NN PennPOS
of	IN	of pp-f NUPOS
a	DT	a dt NUPOS
therapy	NN	therapy NN PennPOS
for	IN	for c-acp NUPOS
idiopathic	JJ	idiopathic JJ PennPOS
pulmonary	JJ	pulmonary JJ PennPOS
fibrosis	NN	fibrosis NN PennPOS
.	.	. . NUPOS

Pirfenidone	NN	Pirfenidone NN PennPOS
(	(	( ( NUPOS
PFD	NN	PFD NN PennPOS
)	)	) ) NUPOS
is	VBZ	be vbz NUPOS
the	DT	the dt NUPOS
first	JJ	first JJ PennPOS
and	CC	and cc NUPOS
only	RB	only av-j NUPOS
clinically	RB	clinical RB PennPOS
used	VBN	use VBN PennPOS
antifibrotic	JJ	antifibrotic JJ PennPOS
drug	NN	drug NN PennPOS
for	IN	for c-acp NUPOS
the	DT	the dt NUPOS
treatment	NN	treatment NN PennPOS
of	IN	of pp-f NUPOS
idiopathic	JJ	idiopathic JJ PennPOS
pulmonary	JJ	pulmonary JJ PennPOS
fibrosis	NN	fibrosis NN PennPOS
(	(	( ( NUPOS
IPF	NN	IPF NN PennPOS
)	)	) ) NUPOS
.	.	. . NUPOS

This	DT	this d NUPOS
study	NN	study NN PennPOS
evaluated	VBD	evaluate VBD PennPOS
the	DT	the dt NUPOS
antifibrotic	JJ	antifibrotic JJ PennPOS
effects	NNS	effect NNS PennPOS
of	IN	of pp-f NUPOS
two	CD	two crd NUPOS
metabolites	NNS	metabolite NNS PennPOS
of	IN	of pp-f NUPOS
PFD	NN	PFD NN PennPOS
,	,	, , NUPOS
5-hydroxypirfenidone	NN	5-hydroxypirfenidone NN PennPOS
(	(	( ( NUPOS
PFD-OH	NN	PFD-OH NN PennPOS
)	)	) ) NUPOS
and	CC	and cc NUPOS
5-carboxypirfenidone	NN	5-carboxypirfenidone NN PennPOS
(	(	( ( NUPOS
PFD-COOH	NN	PFD-COOH NN PennPOS
)	)	) ) NUPOS
,	,	, , NUPOS
on	IN	on IN PennPOS
WI-38	NN	WI-38 NN PennPOS
cells	NNS	cell NNS PennPOS
in	IN	in IN PennPOS
an	DT	a dt NUPOS
in	FW	in fw-la NUPOS
vitro	FW	vitro FW PennPOS
lung	NN	lung NN PennPOS
fibroblast	NN	fibroblast NN PennPOS
model	NN	model NN PennPOS
.	.	. . NUPOS

The	DT	the dt NUPOS
inhibitory	JJ	inhibitory JJ PennPOS
effects	NNS	effect NNS PennPOS
of	IN	of pp-f NUPOS
PFD-OH	NN	PFD-OH NN PennPOS
and	CC	and cc NUPOS
PFD-COOH	NN	PFD-COOH NN PennPOS
on	IN	on IN PennPOS
transforming-growth-factor-b1	NN	transforming-growth-factor-b1 NN PennPOS
(	(	( ( NUPOS
TGF-b1	NN	TGF-b1 NN PennPOS
)	)	) ) NUPOS
-	:	- : NUPOS
induced	VBN	induce VBN PennPOS
collagen	NN	collagen NN PennPOS
synthesis	NN	synthesis NN PennPOS
in	IN	in IN PennPOS
WI-38	NN	WI-38 NN PennPOS
cells	NNS	cell NNS PennPOS
were	VBD	be vbd NUPOS
evaluated	VBN	evaluate VBN PennPOS
by	IN	by IN PennPOS
measuring	VBG	measure VBG PennPOS
intracellular	JJ	intracellular JJ PennPOS
hydroxyproline	NN	hydroxyproline NN PennPOS
,	,	, , NUPOS
a	DT	a dt NUPOS
major	JJ	major JJ PennPOS
component	NN	component NN PennPOS
of	IN	of pp-f NUPOS
the	DT	the dt NUPOS
protein	NN	protein NN PennPOS
collagen	NN	collagen NN PennPOS
.	.	. . NUPOS

PFD-OH	NN	PFD-OH NN PennPOS
and	CC	and cc NUPOS
PFD-COOH	NN	PFD-COOH NN PennPOS
at	IN	at pp NUPOS
300	CD	300 CD PennPOS
and	CC	and cc NUPOS
1000	CD	1000 CD PennPOS
M	NN	m NN PennPOS
concentrations	NNS	concentration NNS PennPOS
significantly	RB	significant av-j NUPOS
decreased	VBD	decrease VBD PennPOS
the	DT	the dt NUPOS
TGF-b1-induced	JJ	tgf-b1-induced JJ PennPOS
hydroxyproline	NN	hydroxyproline NN PennPOS
content	NN	content NN PennPOS
in	IN	in IN PennPOS
WI-38	NN	WI-38 NN PennPOS
cells	NNS	cell NNS PennPOS
.	.	. . NUPOS

These	DT	these d NUPOS
results	NNS	result NNS PennPOS
indicate	VBP	indicate VBP PennPOS
that	IN	that cst NUPOS
PFD-OH	NN	PFD-OH NN PennPOS
and	CC	and cc NUPOS
PFD-COOH	NN	PFD-COOH NN PennPOS
have	VBP	have vhb NUPOS
antifibrotic	JJ	antifibrotic JJ PennPOS
activities	NNS	activity NNS PennPOS
,	,	, , NUPOS
which	WDT	which r-crq NUPOS
inhibit	VBP	inhibit VBP PennPOS
collagen	NN	collagen NN PennPOS
synthesis	NN	synthesis NN PennPOS
in	IN	in IN PennPOS
fibroblasts	NNS	fibroblast NNS PennPOS
.	.	. . NUPOS

This	DT	this d NUPOS
study	NN	study NN PennPOS
suggests	VBZ	suggest VBZ PennPOS
that	IN	that cst NUPOS
the	DT	the dt NUPOS
concentrations	NNS	concentration NNS PennPOS
of	IN	of pp-f NUPOS
PFD	NN	PFD NN PennPOS
and	CC	and cc NUPOS
its	PRP$	its po31 NUPOS
metabolites	NNS	metabolite NNS PennPOS
should	MD	shall vmd NUPOS
be	VB	be vbi NUPOS
considered	VBN	consider VBN PennPOS
in	IN	in IN PennPOS
clinical	JJ	clinical JJ PennPOS
therapy	NN	therapy NN PennPOS
for	IN	for c-acp NUPOS
IPF	NN	IPF NN PennPOS
.	.	. . NUPOS

